Antiarrhythmic Therapy of Ventricular Arrhythmias: The Contemporary Dilemma

Singh BN Implantable cardioverter-defibrillators: Not the ultimate gold standard for gauging therapy of ventricular tachycardia and fibrillation? Am J Cardiol 73:1211, 1994

Zipes DP Implantable cardioverter-defibrillator: Life saver or a device looking for a disease? Circulation 91:2115, 1994

Kim SG Implantable defibrillator therapy: Does it really prolong life? How can we prove it? Am J Cardiol 71:1213, 1993

The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary Report. Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406, 1989

Cardiac Arrhythmia Suppression Trial II Investigators. Ethmozine exerts an adverse effect on mortality in survivors of acute myocardial infarction. N Engl J Med 327:227, 1992

Ahmed R. , Singh BN Antiarrhythmic drugs. Curr Opin Cardiol 8:10, 1993

Singh BN , Ahmed R. Class III antiarrhythmic drugs. Curr Opin Cardiol 19:12, 1993

Siebels J. , Cappato R. , Ruppel R. , Schneider R. , Kuck KH , the CASH Investigators. Preliminary results of the Cardiac Arrest Study Hamburg (CASH). Am J Cardiol 72:109F, 1993

Wever EF , Hauer Rnw , Van Capelle Fjl et al. randomized study of implantable defibrillator as first-choice versus conventional strategy in postinfarct sudden death survivors. Circulation 91:2195, 1995

Singh B. Choice and chance in drug therapy of cardiac arrhythmias: Technique versus drug-specific responses in evaluation of efficacy. Am J Cardiol 72:114, 1993

Connolly SJ , Yusuf S. Evaluations of the implantable cardioverter defibrillator in survivors of cardiac arrest: The need for randomized trials . Am J Cardiol 69:959, 1992

Mason JW , ESVEM Investigators. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 329:452, 1993

Mason JW , ESVEM Investigators. A randomized comparison of electrophysiologic study to electrocardiographic monitoring for prediction of antiarrhythmic drug efficacy in patients with ventricular tachyarrhythmias. N Engl J Med 329:445, 1993

The CASCADE Investigators. The Cascade Study: Randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. Am J Cardiol 72:280, 1993

Lathrop DA , Varro A. , Nanasi PP , Bodi I. , Takyi E. , Pankucsi C. Differences in the effects of d- and dl-sotalol on isolated human ventricular muscle: Electromechanical activity after beta-adrenoceptor stimulation J Cardiovasc Pharmacol Therapeut 1:65, 1996

Nademanee K. , Noll HE , Feld GK Effects of sotalol on His-Purkinje conduction and refractoriness in humans. J Cardiovasc Pharmacol Therapeut 1:9, 1996

Reiffel JA Data driven decisions: The importance of clinical trials in arrhythmia management . J Cardiovasc Pharmacol Therapeut 1:79, 1996

Singh SN , Gross-Fisher S. , Fletcher RD et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmias. N Engl J Med 33:77, 1995

Holnloser S. , Klingenheben T. , Singh BN Amiodarone-associated proarrhythmic effects: A review with special reference to torsades de pointes tachycardia. Ann Intern Med 121:529, 1994

Ziesche S. , Rector TS , Cohn JN Interobserver discordance in the classification of mechanisms of death in studies of heart failure. J Cardiac Failure 1:127, 1995

Waldo AL , Camm AJ , de Ruyter H. , Friedman PL , MacNeil DJ , Pitt B. , Pratt CM , Schwartz PJ , Veltri EP , Sword Investigators. Preliminary mortality results from the Survival with Oral D-Sotalol (SWORD) trial. J Am Coll Cardiol 15A, 1995

Julian DG , Jackson FS , Prescott RJ , Szekely P. Control trial of sotalol for one year after myocardial infarction. Lancet 1:1142, 1982

Holmes J. , Kubo S. , Cody R. , Kligfield P. Arrhythmias in ischemia and nonischemic dilated cardiomyopathy: Prediction of mortality by ambulatory electrocardiography. Am J Cardiol 55:146, 1985

Meinertz TE , Hoffman T. , Kasper W. et al. Significance of ventricular arrhythmias in idiopathic cardiomyopathy. Am J Cardiol 53:902, 1984

Van Olshausen K , Schafer A. , Mehmel HC et al. Ventricular arrhythmia in dilated cardiomyopathy . Br Heart J 51:147, 1984

Doval HC , Nul DR , Vancelli HO et al. Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet 344:493, 1994

CIBIS Investigators and Committees. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 90:1765, 1994

Salerno D. , Gillingam KJ , Berry DA , Hodges M. A comparison of antiarrhythmic drugs for the suppression of ventricular ectopic depolarization: A meta-analysis. Am Heart J 120:340, 1990

Sakai F. , Kawano S. , Hiraoka M. Electrophysiologic effects of beta-blocking agent, tilisolol, on isolated guinea pig ventricular myocytes. J Cardiovasc Pharmacol 1:41, 1996